Drug reference

diroximel

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 402, 403

Overview

Names and pronunciation

(dye-rox′i-mel) Vumerity

PDF page 402

Functional class

Func. class.: MS agent

PDF page 402

Uses

USES: Relapsing multiple sclerosis

PDF page 402

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity

PDF page 402

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES • Adults: PO 231 mg bid for 7 days, then increase to 462 mg bid

PDF page 402

Available forms

Available forms: Delayed-release cap- sule 231 mg HIGH ALERT

PDF pages 402, 403

Dose text by age group

Adults

• Adults: PO 231 mg bid for 7 days, then increase to 462 mg bid

PDF page 402

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

diroximel

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 402, 403

Overview

Names and pronunciation

(dye-rox′i-mel) Vumerity

PDF page 402

Functional class

Func. class.: MS agent

PDF page 402

Uses

USES: Relapsing multiple sclerosis

PDF page 402

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity

PDF page 402

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES • Adults: PO 231 mg bid for 7 days, then increase to 462 mg bid

PDF page 402

Available forms

Available forms: Delayed-release cap- sule 231 mg HIGH ALERT

PDF pages 402, 403

Dose text by age group

Adults

• Adults: PO 231 mg bid for 7 days, then increase to 462 mg bid

PDF page 402

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.